Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Summit Therapeutics Inc (NASDAQ: SMMT) closed at $18.66 in the last session, up 0.65% from day before closing price of $18.54. In other words, the price has increased by $0.65 from its previous closing price. On the day, 1.57 million shares were traded. SMMT stock price reached its highest trading level at $19.5 during the session, while it also had its lowest trading level at $18.2173.
Ratios:
We take a closer look at SMMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.31 and its Current Ratio is at 8.31. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on December 06, 2024, initiated with a Buy rating and assigned the stock a target price of $31.
On November 04, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $32.
Citigroup Downgraded its Buy to Neutral on September 27, 2024, whereas the target price for the stock was revised from $19 to $23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 30,000 shares of SMMT for $112,500 on Mar 26 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $3.75 per share. On Mar 27 ’24, another insider, Zanganeh Mahkam, who serves as the Chief Executive Officer of the company, bought 26,000 shares for $3.72 each. As a result, the insider paid 96,720 and bolstered with 520,814 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 13760779264 and an Enterprise Value of 13306384384.
Stock Price History:
Over the past 52 weeks, SMMT has reached a high of $33.89, while it has fallen to a 52-week low of $2.05. The 50-Day Moving Average of the stock is -5.63%, while the 200-Day Moving Average is calculated to be 61.98%.
Shares Statistics:
According to the various share statistics, SMMT traded on average about 5.18M shares per day over the past 3-months and 1964470 shares per day over the past 10 days. A total of 737.09M shares are outstanding, with a floating share count of 103.50M. Insiders hold about 85.96% of the company’s shares, while institutions hold 11.49% stake in the company. Shares short for SMMT as of 1731628800 were 15987477 with a Short Ratio of 3.09, compared to 1728950400 on 15446534. Therefore, it implies a Short% of Shares Outstanding of 15987477 and a Short% of Float of 13.459999999999999.
